Clinical Study comparing effectiveness of Topical Capsaicin and Oral Pregabalin in treating Diabetic Neuropathy.

Not Applicable

• Conditions: Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

• Registration Number: CTRI/2021/05/033861
• Lead Sponsor: Dr Faizuddin Ahmed

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1) Subjects who are consenting to participate in the study.

2) Subjects must be ambulatory.

3) Subjects should experience at least one symptom of Diabetic Neuropathy in their peripheries like tingling, numbness, burning, and pricking sensation in the limbs.

Exclusion Criteria

1) Subjects who arenâ??t consenting to participate in the study.

2) Subjects below 18 years of age and above 70 years.

3) Subjects with certain comorbid conditions which can trigger neuropathy like, CKD, HIV/AIDS, Vasculitis, Amyloid Polyneuropathy, Sarcoidosis, Guillain-Barre Syndrome, Women with hot flushes (Menopausal period), Postherpetic Neuralgia, Heavy Metal Poisoning, Skin rashes, Erythema, Psoriasis, Scleroderma, Steven- Johnsonâ??s Syndrome, Toxic Epidermal Necrolysis.

4) Subjects with physically debilitating conditions like Rheumatoid Arthritis, Osteoarthritis and other bone and joint disorders. Subjects suffering from physical trauma due to accidents.

5) Subjects who are takin neuropathy-triggering medications like Amiodarone, Cancer chemotherapeutic agents like Platinum based compounds, Paclitaxel, Anti-malarials like Chloroquine, Dapsone, other drugs like Isoniazid, Nitrofurantoin, Carbamazepine, Phenytoin, and Phenobarbital.

Study & Design

• Study Type: Interventional
• Study Design: Not specified